chr2-47798625-C-A
Variant summary
The NM_000179.3(MSH6):c.642C>A (p.Tyr214*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The gene MSH6 is a tumor suppressor gene (CancerMine: 1 TSG, 8 oncogene, 1 driver citations). The gene MSH6 is a known oncogene (CancerMine: 1 TSG, 8 oncogene, 1 driver citations). The gene MSH6 is a cancer driver gene (CancerMine: 1 TSG, 8 oncogene, 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (AlphaMissense) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000179.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 5Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Pathogenic. The variant received 12 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★★) | ||
| O2Null variant in tumour suppressor gene | Frameshift/stop-gained, NMD predicted, LoF oncogenic mechanism — O2 very strong (+8); Use caution in the presence of multiple transcripts; Gene confirmed as TSG in CancerMine (TSG: 1 citations, oncogene: 8 citations, driver: 1 citations).; Frameshift/stop-gained. NMD predicted: true. LoF mechanism: true. Downstream pathogenic count: 2092. | ||
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000179.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH6 | MANE Select | c.642C>A p.Tyr214* | stop_gained | Exon 4 of 10 | Prot: NP_000170.1 UniProt: | |
MSH6 | c.738C>A p.Tyr246* | stop_gained | Exon 5 of 11 | Prot: NP_001393724.1 | ||
MSH6 | c.648C>A p.Tyr216* | stop_gained | Exon 4 of 10 | Prot: NP_001393742.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH6 | TSL:1MANE Select | c.642C>A p.Tyr214* | stop_gained | Exon 4 of 10 | Prot: ENSP00000234420.5 UniProt: | |
MSH6 | TSL:1 | n.472C>A | non_coding_transcript_exon | Exon 3 of 9 | Prot: ENSP00000405294.1 UniProt: | |
MSH6 | c.642C>A p.Tyr214* | stop_gained | Exon 4 of 10 | Prot: ENSP00000606570.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:34 | ||||
GnomAD4 genome | Cov:32 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:760 | AN:180950 | |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Benign | 0.27 | |
BayesDel_addAF | Benign | -0.0023 | T |
BayesDel_noAF | Benign | -0.24 | |
CADD | Benign | 19 | |
DANN | Benign | 0.90 | |
Eigen | Benign | -0.61 | |
Eigen_PC | Benign | -1.0 | |
FATHMM_MKL | Benign | 0.20 | N |
GPN-Star LLR | N/A | -3.5 | |
GPN-Star score | N/A | 3.5 | |
Mutation Taster | N/A | 0/200 | disease causing (ClinVar) |
PhyloP100 | Benign | -2.0 | |
RBP_binding_hub_radar | N/A | 1.1 | |
RBP_regulation_power_radar | N/A | 2.2 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.080 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.